Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Molnupiravir: Clinical Impact of Fenofibrate, a Carboxylesterase 2 Inhibitor. — SciRadar

Back to results

American journal of therapeutics

Molnupiravir: Clinical Impact of Fenofibrate, a Carboxylesterase 2 Inhibitor.

Tsukasa Murata, Masakatsu Sakamoto, Takahiko Nagamine

Published: 202510.1097/MJT.0000000000001932

No abstract available for this study.